NDC 70022-004 - buprenorphine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70022-004
Package NDCs from labels
70022-004-10
Manufacturer
PAYLESS COMPOUNDERS, LLC
Effective date
2024-12-11
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
buprenorphine - PAYLESS COMPOUNDERS, LLCPAYLESS COMPOUNDERS, LLC2024-12-11ANIMAL COMPOUNDED DRUG LABEL
buprenorphine - PAYLESS COMPOUNDERS, LLCPAYLESS COMPOUNDERS, LLC2015-10-21ANIMAL COMPOUNDED DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70022-004-10buprenorphine10 mL in 1 VIAL, MULTI-DOSESOLUTION1010
70022-004-10buprenorphine10 mL in 1 VIAL, MULTI-DOSESOLUTION102

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70022-004BUPRENORPHINE INJECTION, SOLUTION BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]101 package rows20241213_a1c1f498-e101-467f-b81c-1451c44e7a01.zip
70022-004BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]21 package rows20151022_c385095b-152a-45fd-8c49-3e44493e9a00.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BUPRENORPHINE HYDROCHLORIDEACTIVE INGREDIENT56W8MW3EN1BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]2
BUPRENORPHINEACTIVE MOIETY40D3SCR4GZBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]2
ANHYDROUS DEXTROSEINACTIVE INGREDIENT5SL0G7R0OKBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]2
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]2
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]2
MANNITOLINACTIVE INGREDIENT3OWL53L36ABUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]2
WATERINACTIVE INGREDIENT059QF0KO0RBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]2
BUPRENORPHINE HYDROCHLORIDEACTIVE INGREDIENT56W8MW3EN1BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1
BUPRENORPHINEACTIVE MOIETY40D3SCR4GZBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1
SUCROSEINACTIVE INGREDIENTC151H8M554BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1
WATERINACTIVE INGREDIENT059QF0KO0RBUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 26 of 26 · 507 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AdditoxTRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUMBioActive Nutritional, Inc.319ee2fe-58e3-495e-bf0d-df201f6fbb1c2018-07-18WarningsExact identifier
unii: OJ245FE5EU
unii: 1Q73Q2JULR
unii: Z8IX2SC1OH
unii: A2I8C7HI9T
Ivy-Dry SuperBENZYL ALCOHOL, CAMPHOR, MENTHOLIvy-Dry, Inc.4792a667-2378-4b3d-968d-9efb1866792f2017-12-27WarningsExact identifier
unii: LKG8494WBH
Homeoplex DGLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM,Supplement Clinic, LLC.cd6b48ab-3566-484d-8deb-15ef6f8e7e8f2017-11-01WarningsExact identifier
unii: LKG8494WBH
Sterile WaterWATERBaxter Healthcare Corporationef3e79c5-3f58-4b36-a296-64b7d9a651c12017-10-17Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
Eye WashWATERCVS Pharmacy049cee29-7ec2-4d5b-8308-f522acde43a72017-03-29WarningsExact identifier
unii: 059QF0KO0R
Sterile WaterWATERBaxter Healthcare Company210dc9ab-d6ca-4552-ac19-1be17792d2902016-05-31Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.051f7347-5a76-4664-8fe2-e61b3dfcb0e42014-08-27Exact identifier
unii: XF417D3PSL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.